This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Health Care Buys Ahead of Earnings

3. Jazz Pharmaceuticals (JAZZ - Get Report) is a specialty pharmaceutical company with two products: Xyrem and Luvox CR. Jazz will announce third-quarter results on Nov. 1.

For the third quarter of 2011, net income is seen increasing to $40.60 million from $17.25 million in the year-ago quarter. Earnings per share are estimated at 92 cents, up from 41 cents in the prior-year period. Sales are seen rising 61% to $72.18 million from $44.75 million in the same quarter prior year. Gross margin is likely to expand to 94.73% from 93.09% in the year-ago period.

Of the six analysts covering the stock, four recommend a buy and two suggest a hold. Analysts polled by Bloomberg expect the stock to gain almost 34.2% to $53.50 from current levels over the next 12 months.

6 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
JAZZ $183.09 -3.30%
HSIC $139.98 -1.80%
MD $72.78 -0.86%
MYGN $33.97 1.10%
PFE $34.59 -1.90%


DOW 18,031.13 -49.01 -0.27%
S&P 500 2,109.67 -8.02 -0.38%
NASDAQ 5,057.5940 -34.4910 -0.68%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs